Bertrand Georges

Bertrand Georges

Company: Altimmune

Job title: Chief Technology Officer

Seminars:

HepTcell as Immunotherapy to Achieve Functional Cure for Chronic HBV 2:00 pm

• Chronic hepatitis B is characterized by immune tolerance, and functional cure can only be achieved by restoring T cell function • T cell epitopes from Core and Polymerase antigens, conserved across HBV genotypes represent attractive targets for the development of safe and effective HBV immunotherapeutic • An immunotherapeutic agent will be effective at an…Read more

day: Day Two

Panel Discussion: Defining Clinical Endpoints & Exploring Surrogates for HBV Functional Cure 8:30 am

• Reflecting cccDNA activity and assessing durability of hepatitis B surface antigen seroclearance • Outlining parameters for acceptable and clinically meaningful hepatitis B surface antigen loss and opportunities to implement alternative surrogate endpoints • Future directions: looking towards a sterilizing cureRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.